Should we prescribe abstinence or wine once a day with supper in diabetes and prediabetes?
Main Article Content
Abstract
The ultimate goal of diabetes management is to minimize complications and maintain quality of life in the context of comprehensive cardiovascular risk management and patient-centered care. This includes lifestyle management and diabetes self-management education and support. In contrast to current pharmacological guidelines, which are patient-centered and evidence based, lifestyle guidelines still carry potential for improvement. Despite current best evidence from prospective controlled trials showing, that moderate wine consumption is associated with survival benefit, reduced risk of cardiovascular endpoints in both subjects with and without diabetes as well as reduced diabetes incidence in the context of the mediterranean diet, translation into clinical practice is unsatisfactory. Patients with diabetes and prediabetes need balanced and accurate information so they can make informed decisions about the risk-benefit balance of the traditional mediterranean drinking pattern and translate it into their personal lifestyle and diabetes self-management – if applicable and suitable.
In this regard, balanced analysis of the available evidence as a counterbalance to notorious myths is necessary. This requires consideration of the broader context of european art of living, of direct and indirect effects of ethanol on glucose and lipid metabolism, distinction between harmful (binge drinking) and beneficial (regular with meals) drinking patterns, distinction between distilled (spirits) and fermented (wine and beer) beverages, appreciation of the phenomenon of dose-dependent effect reversal (hormesis or J-curve), which is common to all alcoholic beverages and finally respect of ethnical and regional as well as gender- and age-related differences.
Downloads
Article Details
Copyright (c) 2020 Rett K.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Hippocrates. of the epidemics. In: Hippocrates Collected Works I. Jones WHS (1868) Cambridge. Harvard University Press.
Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, et al. (2018) Management of hyperglycaemia in type 2 diabetes. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 61: 2461–2498.
Shai I et al (2008) Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359: 229-241.
Mozaffarian D, Appel LJ, Van Horn L (2011) Components of a cardioprotective diet. New insights. Circulation 123: 2870-2891. Link: https://bit.ly/2Xug9l0
American Diabetes Association (2017) Lifestyle management. Sec. 4. In Standards of Medical Care in Diabetes. Diabetes Care 40: S33-S43.
Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KH, et al. (2019) Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care 42: 731-754. Link: https://bit.ly/2TyCyfJ
Trichopoulou A, Costacou T, Bamia C, Trichopoulos D (2003) Adherence to a Mediterranean Diet and Survival in a Greek Population. N Engl J Med 348: 2599-2608. Link: https://bit.ly/2Zyr93u
Neuenschwander M, Ballon A, Weber KS, Norat T, Aune D, et al. (2020) Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ 366: l2368. Link: https://bit.ly/3gl2Zzp
Fung TT, Rexrode KM, Mantzoros CS, Mansoon JE, Willett WC, et al. (2009) Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 119: 1093-1100. Link: https://bit.ly/2ZzjulC
Buckland G, Agudo A, Travier N, Huerta JM, Cirera L, et al. (2011) Adherence to the Mediterranean diet reduces mortality in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Br J Nutr 106: 1581-1591. Link: https://bit.ly/36Ap5tq
Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, et al. (2018) Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med 378: 1279-1290. Link: https://bit.ly/36uu3rw
Bonaccio M, Di Castelnuovo A, Costanzo S, Persichillo M, De Curtis A, et al (2016) on behalf of the MOLI-SANI Study Investigators. Adherence to the traditional Mediterranean diet and mortality in subjects with diabetes. Eur J Prev Cardiol 23: 400-407. Link: https://bit.ly/3dd5AcA
O’Connor LE, Hu EA, Steffen LM, Selvin E, Rebholz CM, et al. (2020) Adherence to a Mediterranean-style eating pattern and risk of diabetes in a U.S. prospective cohort study. Nutrition and Diabetes 10: 8. Link: https://go.nature.com/2XwgcwC
Boban M, Stockley C, Teissedre PL, Restani P, Fradera U, et al. (2016) Drinking pattern of wine and effects on human health: why should we drink moderately and with meals? Food Funct 7:2937–2942. Link: https://bit.ly/2X1910u
Schutte R, Papageorgiou M, Najlah M, Huisman HW, Ricci C, et al. (2020) Drink types unmask the healthy risks associated with alcohol intake. Prospective evidence from the general population. Clinical Nutrition Link: https://bit.ly/3d38y3r
Beulens JWJ, Kruidhof JS, Grobbee DE, Chaturvedi N, Fuller FH, et al. (2008) Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EU-RODIAB Prospective Complications Study. Diabetologia 51: 1631–1638. Link: https://bit.ly/2TzqYB8
Esposito K, Maiorino MI, Ceriello A, Giugliano D (2010) Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract 89: 97–102. Link: https://bit.ly/3ejEsJ4
Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, et al. (2018) Risk Thresholds for Alcohol Consumption: Combined Analysis of Individual-Participant Data for 599 912 Current Drinkers in 83 Prospective Studies. Lancet 391: 1513-1523. Link: https://bit.ly/2WYvlb2
Gakidou E, Griswold MG, Fullman N, Hawley CN, Arian N, et al. (2018) Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study Lancet 392: 1015-1035. Link: https://bit.ly/2AWZajH
Noorden C, Isaac S (1901) Die Zuckerkrankheit und ihre Behandlung. 3. Auflage, 4. Kapitel S. 83; August Hirschwald, Berlin. Link: https://bit.ly/2A35oyf ´
Turner BC, Jenkins E, Kerr D, Sherwin RS, Cavan DA (2001) The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care 24: 1888-1893. Link: https://bit.ly/3gmJdnl
Siler SQ, Neese RA, Hellerstein MK (1999) De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. Am J Clin Nutr 70: 928-936. Link: https://bit.ly/2M2uiAt
Yu B, Schroeder A, Nagy LE (2000) Ethanol stimulates glucose uptake and translocation of GLUT-4 in H9c2 myotubes via a Ca2+-dependent mechanism. Am J Physiol Endocrinol Metab 279: E1358-E1365. Link: https://bit.ly/3c7eVBK
Heiss C, Keen CL, Kelm M (2010) Flavanols and cardiovascular disease prevention. Eur Heart J actions 31: 2583-2592. Link: https://bit.ly/3gmsrEQ
Tresserra-Rimbau A, Guasch-Ferrė M, Salas-Salvadó J (2016) Intake of Total Polyphenols and Some Classes of Polyphenols Is Inversely Associated with Diabetes in Elderly People at High Cardiovascular Disease Risk. J Nutr 146: 767–777. Link: https://bit.ly/3eflIdL
Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, et al. (2007) Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370: 829-840. Link: https://bit.ly/2WXMGB2
The ADVANCE Collaborative Group (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572. Link: https://bit.ly/3c0b74Y
Blomster JI, Zoungas S, Chalmers J, Li Q, Chow CK, et al. (2014) The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. Diabetes Care 37: 1353-1359. Link: https://bit.ly/2ZAD6G4
Li H, Borinskaya S, Yoshimura K, Kal'ina N, Marusin A, et al. (2009) Refined geographic distribution of the oriental ALDH2*504lys variant. Ann Hum Genet 73: 335-334. Link: https://bit.ly/36EqlMd
Gepner Y, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, et al. (2015) Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes. A 2-Year Randomized, Controlled Trial. Ann Intern Med 163: 569-579. Link: https://bit.ly/3elte7b
Gepner Y, Henkin Y, Schwarzfuchs D, Golan R, Durst R, et al. (2016) Differential Effect of Initiating Moderate Red Wine Consumption on 24-h Blood Pressure by Alcohol Dehydrogenase Genotypes: Randomized Trial in Type 2 Diabetes. Am J Hypertens 29: 476-483. Link: https://bit.ly/2zsyfMm
Golan R, Shelef I, Shemesh E, Henkin Y, Schwarzfuchs D, et al. (2017) Effects of initiating moderate wine intake on abdominal adipose tissue in adults with type 2 diabetes: a 2-year randomized controlled trial. Public Health Nutr 20: 549-555. Link: https://bit.ly/2XyiLyy